Lisocabtagene Maraleucel as Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplant: Final Analysis of the Phase 2 PILOT Study Sehgal, A. R., Hoda, D., Riedell, P. A., Ghosh, N., Hamadani, M., Hildebrandt, G., Godwin, J. E., Reagan, P. M., Wagner-Johnston, N., Essell, J., Nath, R., Solomon, S. R., Champion, R., Licitra, E., Fanning, S., Gupta, N. K., Chow, V. A., Yuan, B., Yang, Z., Ogasawara, K., Thorpe, J., Gordon, L. I. AMER SOC HEMATOLOGY. 2023

View details for DOI 10.1182/blood-2023-180952

View details for Web of Science ID 001159306700106